Anti-Zinc finger antiviral protein antibody
4
(2 Reviews)
|
(18 Publications)
Rabbit Polyclonal Zinc finger antiviral protein antibody. Suitable for WB, ICC/IF, IHC-P and reacts with Human samples. Cited in 18 publications. Immunogen corresponding to Recombinant Fragment Protein within Human ZC3HAV1 aa 400 to C-terminus.
View Alternative Names
ZC3HDC2, PRO1677, ZC3HAV1, Zinc finger CCCH-type antiviral protein 1, ADP-ribosyltransferase diphtheria toxin-like 13, Inactive Poly [ADP-ribose] polymerase 13, Zinc finger CCCH domain-containing protein 2, Zinc finger antiviral protein, ARTD13, PARP13, ZAP
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Zinc finger antiviral protein antibody (AB154680)
Immunofluorescence analysis of HeLa cells fixed in 4% paraformaldehyde at RT for 15 min labelling ZC3HAV1 protein at cytoplasm using ab154680 at a 1/1000 dilution (Green). DAPI was used for nuclear staining (Blue). Scale bar = 10 µm
- WB
Supplier Data
Western blot - Anti-Zinc finger antiviral protein antibody (AB154680)
Samples were separated by 7.5% SDS-PAGE.
All lanes:
Western blot - Anti-Zinc finger antiviral protein antibody (ab154680) at 1/10000 dilution
Lane 1:
293T whole cell lysates at 30 µg
Lane 2:
A431 whole cell lysates at 30 µg
Lane 3:
HeLa whole cell lysates at 30 µg
Lane 4:
HepG2 whole cell lysates at 30 µg
Secondary
All lanes:
HRP conjugated anti rabbit IgG antibody
Predicted band size: 101 kDa
false
- WB
CiteAb
Western blot - Anti-Zinc finger antiviral protein antibody (AB154680)
Western Blotting using Anti-Zinc finger antiviral protein antibody, ab154680. Publication image from Odon, V. et al., 2019, Nucleic Acids Res, 31276592. Legend direct from paper.
Binding of affinity isolated ZAP to CpG-H and UpA-H RNA transcripts. (A) ZAP detection by WB in input A549 cell lysates before and after immunoprecipitation (IP) with anti-ZAP or irrelevant antibody control (lower panel; IP). Long and short isoforms of ZAP migrated at around 90 and 75 KDa, respectively. The negative control was mock transfected (no viral RNA control). (B) Quantitation of E7 viral RNA transcripts with WT, CpG-high and UpA-high R2 sequences by qPCR in immunoprecipitated ZAP (right column) or mock precipitated control (left column). Bar heights show the mean of two biological experiments, errors bars show standard errors of the mean. The no RNA transcript control was negative by qPCR (data not shown).
false
- WB
CiteAb
Western blot - Anti-Zinc finger antiviral protein antibody (AB154680)
Western Blotting using Anti-Zinc finger antiviral protein antibody, ab154680. Publication image from Odon, V. et al., 2019, Nucleic Acids Res, 31276592. Legend direct from paper.
Expression of ZAP, RNAseL and OAS3 in cell lines; association of ZAP expression with attenuation. Detection of ZAP-L and ZAP-S (A) and RNAseL, and OAS3 (B) by western blot analysis of lysates of different cell lines before and after stimulation with exogenous IFN-β. (C) Association of ZAP-L expression with the attenuation index of mutants of E7 with high CpG or UpA 3′UTR sequences. The black and grey dotted lines show lines of best fit and associated R values. Significance levels were based on one-tailed probabilities using the Spearman non-parametric test.
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Zinc finger antiviral protein serves a critical role in the innate immune response. ZAP is part of a complex involving several cofactors that facilitate its antiviral activity. This protein collaborates with TRIM25 and AGO2 to recruit RNA degradation machinery targeting viral mRNA for decay. ZAP's interactions highlight its importance in the cellular response to viral infection making it an attractive target for developing antiviral therapies.
Pathways
Zinc finger antiviral protein is integral to the interferon signaling and viral RNA degradation pathways. Interferon signaling initiates the expression of ZAP linking it with other interferon-stimulated genes to enhance the antiviral response. Within the RNA degradation pathway ZAP coordinates with proteins like TRIM25 augmenting the destruction of viral genetic material. These pathways highlight the protein's role in suppressing viral replication and promoting cell survival during infections.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (18)
Recent publications for all applications. Explore the full list and refine your search
The Journal of biological chemistry 301:108336 PubMed39984050
2025
Applications
Unspecified application
Species
Unspecified reactive species
JACC. Basic to translational science 9:792-807 PubMed39070274
2024
Applications
Unspecified application
Species
Unspecified reactive species
Viruses 16: PubMed39066196
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of general virology 104: PubMed38063292
2023
Applications
Unspecified application
Species
Unspecified reactive species
Viruses 15: PubMed37112813
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of virology 97:e0184622 PubMed36916924
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of virology 97:e0087222 PubMed36633408
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in microbiology 13:975632 PubMed36160209
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of virology 96:e0052622 PubMed35913217
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cells 10: PubMed34572049
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com